Abstract
Stability studies are pivotal necessities for ensuring safety, potency, and quality of drug products throughout their shelf-life. These guarantee that pharmaceutical products will remain stable and effective under the recommended storage conditions and are considered as prerequisite for approval of any pharmaceutical product. Stability tests are routine procedures that are conducted under different conditions for investigating the effect of variation in temperature, humidity, light intensity, and time on pharmaceutical products. Hence, these studies should be conducted and evaluated according to guidelines issued by ICH (International Conference on Harmonization) or WHO. In this chapter, we have discussed the types and methods of stability tests, storage conditions, as well as ICH and WHO guidelines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Preparations WECoSfP (2018) Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. WHO Technical Report Series (1010)
Bajaj S, Singla D, Sakhuja N (2012) Stability testing of pharmaceutical products. J App Pharm Sci 2(3):129–138
Aashigari S, Goud R, Sneha S, Vykuntam U, Potnuri NR (2018) Stability studies of pharmaceutical products. World J Pharm Res 8:479–492
Siddiqui FA, Sher N, Shafi N, Wafa Sial A, Ahmad M, Naseem H (2014) Development of new method for simultaneous analysis of piracetam and levetiracetam in pharmaceuticals and biological fluids: application in stability studies. Biomed Res Int 2014
Jamrógiewicz M (2016) Consequences of new approach to chemical stability tests to active pharmaceutical ingredients. Front Pharmacol 7:17
World Health Organization, Meeting WECoSfPP (2015) WHO expert committee on specifications for pharmaceutical preparations: forty-ninth report. World Health Organization, Geneva
World Health Organization, Preparations WECoSfP (2017) Fifty-first report of the WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organization, Geneva
World Health Organization (2011) Guidelines on submission of documentation for a multisource (generic) finished product: general format: preparation of product dossiers in common technical document format. WHO expert committee on specifications for pharmaceutical preparations Annex;5
Meeting WECoSfPP, World Health Organization (2016) WHO expert committee on specifications for pharmaceutical preparations: fiftieth report. World Health Organization, Geneva
Zilker M, Sörgel F, Holzgrabe U (2019) A systematic review of the stability of finished pharmaceutical products and drug substances beyond their labeled expiry dates. J Pharm Biomed Anal 166:222–235
Yasmeen A, Sofi G (2019) A review of regulatory guidelines on stability studies. J Phytopharmacol 8(3):147–151
Rao G, Goyal A (2016) Development of stability indicating studies for pharmaceutical products: an innovative step. Int Jr Pharm Chem Anal 3(3):110–116
Sautou V, Brossard D, Chedru-Legros V, Crauste-Manciet S, Lagarce F, Odou P (2013) Methodological guidelines for stability studies of hospital pharmaceutical preparations. SFPC GERPAC 75
Panda A, Kulkarni S, Tiwari R (2013) Stability studies: an integral part of drug development process. Int J Pharma Res Bio Sci 2(6):69–80
Narayan S, Choudhary M (2017) A review on stability studies of pharmaceutical products. Int J of Appl Pharm Bio Res 2(3):67–75
Singh DK, Singh S, Bajaj S (2018) Regulatory guidelines on stability testing and trending of requirements. Methods for stability testing of pharmaceuticals. Springer, New York, pp 1–30
Thorat P, Warad S, Solunke R, Sargar A, Bhujbal A, Shinde A (2014) Stability study of dosage form: an innovative step. World J Pharm Pharm Sci 3(2):1031–1050
Bajaj S, Singh S. (2018) Methods for stability testing of pharmaceuticals: Springer. New York
Pokharana M, Vaishnav R, Goyal A, Shrivastava A (2018) Stability testing guidelines of pharmaceutical products. J Drug Deliv Ther 8(2):169–175
Lachman L, Lieberman HA, Kanig JL (1986) The theory and practice of industrial pharmacy. Lea & Febiger, Philadelphia
Bott RF, Oliveira WP (2007) Storage conditions for stability testing of pharmaceuticals in hot and humid regions. Drug Dev Ind Pharm 33(4):393–401
Honmane SM (2017) General considerations of design and development of dosage forms: pre-formulation review. Asian J Pharm 11:03
Shah AK, Agnihotri SA (2011) Recent advances and novel strategies in pre-clinical formulation development: an overview. J Control Release 156(3):281–296
Garnero C, Zoppi A, Aloisio C, Longhi MR (2018) Technological delivery systems to improve biopharmaceutical properties. In: Nanoscale fabrication, optimization, scale-up and biological aspects of pharmaceutical nanotechnology. Elsevier, Oxford, pp 253–299
Zhou D, Porter WR, Zhang GG (2009) Drug stability and degradation studies. In: Developing solid oral dosage forms. Elsevier, pp 87–124
Qiu Y, He X, Zhu L, Chen B (2017) Product and process development of solid oral dosage forms. In: Developing solid oral dosage forms. Elsevier, pp 555–591
Zhou D, Qiu Y (2010) Understanding drug properties in formulation and process design of solid oral products. J Valid Technol 16(4):74
Denyer SP, Hodges NA, Gorman SP (2008) Hugo and Russell’s pharmaceutical microbiology. Wiley, New York
Sandle T (2011) A review of cleanroom microflora: types, trends, and patterns. PDA J Pharm Sci Technol 65(4):392–403
Dao H, Lakhani P, Police A, Kallakunta V, Ajjarapu SS, Wu K-W et al (2018) Microbial stability of pharmaceutical and cosmetic products. AAPS PharmSciTech 19(1):60–78
Bhagyashree P, Karishma G, Sampada A, Ankita P, Pratibha C, Kailash V (2015) Recent trends in stability testing of pharmaceutical products: a review. Res J Pharm Biol Chem Sci 6(1):1557–1569
Blessy M, Patel RD, Prajapati PN, Agrawal Y (2014) Development of forced degradation and stability indicating studies of drugs—a review. J Pharm Anal 4(3):159–165
Abellán EFG, Pérez DM (2018) Quality control of cosmetic products: specific legislation on ingredients. In: Analysis of cosmetic products. Elsevier, pp 39–53
Lerche D, Sobisch T (2011) Direct and accelerated characterization of formulation stability. J Dispers Sci Technol 32(12):1799–1811
Lin T-YD, Chen CW (2003) Overview of stability study designs. J Biopharm Stat 13(3):337–354
Kopp S (2006) Stability testing of pharmaceutical products in a global environment. Regul Aff J 16(5):291–294
Huynh-Ba K (2009) Pharmaceutical stability testing to support global markets. Springer, New York
Kaur M, Kaur G, Kaur H, Sharma S (2013) Overview on stability studies. Int J Pharm Chem Biol Sci 3:4
Khan H, Ali M, Ahuja A, Ali J (2010) Stability testing of pharmaceutical products-comparison of stability testing guidelines. Curr Pharm Anal 6(2):142–150
Teasdale A, Elder D, Nims RW (2017) ICH quality guidelines. Wiley Online Library, Hoboken
Elder D, Teasdale A (2017) ICH Q9 quality risk management. In: ICH quality guidelines: an implementation guide. Wiley, Hoboken, pp 579–610
Chinchole AS, Poul B, Panchal C, Chavan D (2014) A review on stability guidelines by ICH and USFDA guidelines for new formulation and dosage form. PharmaTutor 2(8):32–53
Guideline IHT (2003) Stability testing of new drug substances and products. Q1A (R2), current step 4:1–24
Eggert J, Fowler C (2008) Conducting stability studies during development to ensure successful regulatory approval. Drugs Pharm Sci 181:207
Bhavyasri K, Vishnumurthy KM, Rambabu D, Sumakanth M (2019) ICH guidelines–“Q” series (quality guidelines)-A review. GSC Biol Pharm Sci 6(3):089–106
Baertschi SW, Alsante KM, Tønnesen HH (2010) A critical assessment of the ICH guideline on photostability testing of new drug substances and products (Q1B): recommendation for revision. J Pharm Sci 99(7):2934–2940
Huynh-Ba K (2008) Handbook of stability testing in pharmaceutical development: regulations, methodologies, and best practices. Springer, New York
Huynh-Ba K (2009) Stability operation practices. Handbook of stability testing in pharmaceutical development. Springer, New York, pp 303–320
Subbarao N, Huynh-Ba K (2009) Evaluation of stability data. Handbook of stability testing in pharmaceutical development. Springer, pp 263–283
Capen R, Christopher D, Forenzo P, Huynh-Ba K, LeBlond D, Liu O et al (2018) Evaluating current practices in shelf life estimation. AAPS PharmSciTech 19(2):668–680
Avohou TH, Lebrun P, Rozet E, Boulanger B (2020) Bayesian methods for the design and analysis of stability studies. In: Bayesian methods in pharmaceutical research
Stroup WW, Quinlan M (2016) Statistical considerations for stability and the estimation of shelf life. Nonclinical statistics for pharmaceutical and biotechnology industries. Springer, Cham, pp 575–604
Mazzeo A, Carpenter P (2009) Stability studies for biologics. In: Huynh-Ba K (ed) Handbook of stability testing in pharmaceutical development. Springer, New York, pp 353–369
Toth SJ (2014) Nonlinear optical imaging of pharmaceutical formulations. Purdue University
Bajaj S, Singla D, Sakhuja N (2012) Stability testing of pharmaceutical products. J App Pharm Sci 2(3):129–138
Centanni JM, Roy MJ (2016) Biotechnology operations: principles and practices. CRC Press, Boca Raton
Kumar N, Jha A (2017) Temperature excursion management: a novel approach of quality system in pharmaceutical industry. Saudi Pharm J 25(2):176–183
Narang AS, Desai D, Badawy S (2015) Impact of excipient interactions on solid dosage form stability. Excipient applications in formulation design and drug delivery. Springer, pp 93–137.
Hanlon G, Hodges NA (2012) Essential microbiology for pharmacy and pharmaceutical science. Wiley, Chichester
Mohamed AI, Abd-Motagaly AME, Ahmed OA, Amin S, Ali M, Ibrahim A (2017) Investigation of drug–polymer compatibility using chemometric-assisted UV-spectrophotometry. Pharmaceutics 9(1):7
Murthy SN, Repka MA (2018) Excipient stability: a critical aspect in stability of pharmaceuticals. AAPS Pharm Sci Tech 19(1):11–11
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Haider, K., Akash, M.S.H., Faheem, A., Rehman, K. (2020). Guidelines for Drug Stability and Stability Testing. In: Akash, M.S.H., Rehman, K. (eds) Drug Stability and Chemical Kinetics. Springer, Singapore. https://doi.org/10.1007/978-981-15-6426-0_2
Download citation
DOI: https://doi.org/10.1007/978-981-15-6426-0_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-6425-3
Online ISBN: 978-981-15-6426-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)